The upcoming synthetic ultrapotent opioid wave as a foreseeable disaster.
作者信息
Krausz R Michael, Westenberg Jean N, Meyer Maximilian, Choi Fiona
机构信息
Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada; Center for Addictive Disorders, University Psychiatric Clinics Basel, University of Basel, Basel, Switzerland.
出版信息
Lancet Psychiatry. 2022 Sep;9(9):699-700. doi: 10.1016/S2215-0366(22)00241-3.
Abstract
摘要
相似文献
1
The upcoming synthetic ultrapotent opioid wave as a foreseeable disaster.
Lancet Psychiatry. 2022 Sep;9(9):699-700. doi: 10.1016/S2215-0366(22)00241-3.
2
Psychiatric Comorbidity and Substance Use Outcomes in an Office-Based Buprenorphine Program Six Months Following Hurricane Sandy.
Subst Use Misuse. 2015;50(12):1571-8. doi: 10.3109/10826084.2015.1023455. Epub 2015 Nov 19.
3
[Ethical Duties in Disaster Preparedness.].
Rev Esp Salud Publica. 2022 Oct 5;96:e202210071.
4
Abuse deterrence focus of upcoming opioid formulations.
Am J Health Syst Pharm. 2008 Mar 1;65(5):381, 385. doi: 10.2146/news080018.
5
The criminalization of treating end of life patients with risky pain medication and the role of the extreme emergency situation.
Fordham Law Rev. 2007 Oct;76(1):203-34.
6
Dr. Pou and the hurricane--implications for patient care during disasters.
N Engl J Med. 2008 Jan 3;358(1):1-5. doi: 10.1056/NEJMp0707917.
7
Selective attrition and bias in a longitudinal health survey among survivors of a disaster.
BMC Med Res Methodol. 2007 Feb 15;7:8. doi: 10.1186/1471-2288-7-8.
8
Perspectives on cannabis as a substitute for opioid analgesics.
Pain Manag. 2019 Mar 1;9(2):191-203. doi: 10.2217/pmt-2018-0051. Epub 2019 Jan 25.
9
President's message: Deliberate epidemics.
J Addict Dis. 2017 Oct-Dec;36(4):264-265. doi: 10.1080/10550887.2017.1390329.
10
AH-7921: a new synthetic opioid of abuse.
Drug Alcohol Rev. 2015 Jan;34(1):109-10. doi: 10.1111/dar.12216. Epub 2014 Oct 10.
引用本文的文献
1
Early identification of the use of potent benzylbenzimidazoles (nitazenes) through wastewater analysis: Two years of data from 22 countries.
Addiction. 2025 Mar 18. doi: 10.1111/add.70027.
2
The implementation of safer drug consumption facilities in Scotland: a mixed methods needs assessment and feasibility study for the city of Edinburgh.
Harm Reduct J. 2025 Jan 13;22(1):6. doi: 10.1186/s12954-024-01144-1.
3
Challenges for the implementation of injectable opioid agonist treatment: a scoping review.
Harm Reduct J. 2024 Dec 4;21(1):217. doi: 10.1186/s12954-024-01102-x.
4
Hazardous Materials from Threats to Safety: Molecularly Imprinted Polymers as Versatile Safeguarding Platforms.
Polymers (Basel). 2024 Sep 24;16(19):2699. doi: 10.3390/polym16192699.
5
[Challenges in the treatment of opioid dependence].
Nervenarzt. 2024 Sep;95(9):811-817. doi: 10.1007/s00115-024-01691-9. Epub 2024 Jul 15.
6
Preference for hotline versus mobile application/countdown-based mobile overdose response services: a qualitative study.
Harm Reduct J. 2024 Feb 5;21(1):31. doi: 10.1186/s12954-024-00944-9.
7
Shifting drug markets in North America - a global crisis in the making?
Int J Ment Health Syst. 2023 Oct 25;17(1):36. doi: 10.1186/s13033-023-00601-x.
8
A Call for an Evidence-Based Strategy Against the Overdose Crisis.
Can J Psychiatry. 2024 Jan;69(1):5-9. doi: 10.1177/07067437231188202. Epub 2023 Jul 12.
9
Detection, chemical analysis, and pharmacological characterization of dipyanone and other new synthetic opioids related to prescription drugs.
Anal Bioanal Chem. 2023 Sep;415(21):5165-5180. doi: 10.1007/s00216-023-04722-7. Epub 2023 May 13.
10
Safety and feasibility of intranasal heroin-assisted treatment: 4-week preliminary findings from a Swiss multicentre observational study.
Harm Reduct J. 2023 Jan 7;20(1):2. doi: 10.1186/s12954-023-00731-y.
本文引用的文献
1
Modeling the evolution of the US opioid crisis for national policy development.
Proc Natl Acad Sci U S A. 2022 Jun 7;119(23):e2115714119. doi: 10.1073/pnas.2115714119. Epub 2022 May 31.
2
Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole 'nitazene' synthetic opioid.
Arch Toxicol. 2022 Jun;96(6):1845-1863. doi: 10.1007/s00204-022-03276-4. Epub 2022 Apr 28.
3
Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.
Lancet. 2022 Feb 5;399(10324):555-604. doi: 10.1016/S0140-6736(21)02252-2. Epub 2022 Feb 2.
4
Shifting North American drug markets and challenges for the system of care.
Int J Ment Health Syst. 2021 Dec 20;15(1):86. doi: 10.1186/s13033-021-00512-9.
Zotero 插件